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Abstract
Background: Characterizing infectious disease burden in Africa is important for prioritizing and targeting limited resources
for curative and preventive services and monitoring the impact of interventions.
Methods: From June 1, 2006 to May 31, 2008, we estimated rates of acute lower respiratory tract illness (ALRI), diarrhea and acute
febrile illness (AFI) among.50,000 persons participating in population-based surveillance in impoverished, rural western Kenya
(Asembo) and an informal settlement in Nairobi, Kenya (Kibera). Field workers visited households every two weeks, collecting
recent illness information and performing limited exams. Participants could access free high-quality care in a designated referral
clinic in each site. Incidence and longitudinal prevalence were calculated and compared using Poisson regression.
Results: Incidence rates resulting in clinic visitation were the following: ALRI — 0.36 and 0.51 episodes per year for children
,5 years and 0.067 and 0.026 for persons $5 years in Asembo and Kibera, respectively; diarrhea — 0.40 and 0.71 episodes
per year for children ,5 years and 0.09 and 0.062 for persons $5 years in Asembo and Kibera, respectively; AFI — 0.17 and
0.09 episodes per year for children ,5 years and 0.03 and 0.015 for persons $5 years in Asembo and Kibera, respectively.
Annually, based on household visits, children ,5 years in Asembo and Kibera had 60 and 27 cough days, 10 and 8 diarrhea
days, and 37 and 11 fever days, respectively. Household-based rates were higher than clinic rates for diarrhea and AFI, this
difference being several-fold greater in the rural than urban site.
Conclusions: Individuals in poor Kenyan communities still suffer from a high burden of infectious diseases, which likely
hampers their development. Urban slum and rural disease incidence and clinic utilization are sufficiently disparate in Africa
to warrant data from both settings for estimating burden and focusing interventions.
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Introduction
Most childhood deaths today occur in Sub-Saharan Africa, and
over three-quarters of these deaths are due to infectious diseases [1].
Adults in Africa, who bear a disproportionate share of the world’s
HIV/AIDS epidemic, also have the highest mortality rates in the
world [2]. Characterizing burden of infectious disease syndromes in
Africa is important for targeting and prioritizing use of limited
resources for optimal curative and preventive services and for
research and development of novel strategies and interventions.
Moreover, longitudinal surveillance of disease burden is important
in monitoring impact of these public health expenditures. In Africa,
the majority of cases of acute infectious illnesses do not present at
health facilities [3,4], and most deaths occur at home [5].
Community-based, household surveillance can supplement facili-
ty-based surveillance to define disease burden and measure impact
of public health interventions. Nonetheless, few community-based
studies of disease burden in Africa exist, and most that have been
done took place before the widespread introduction of interventions
that substantially reduced disease burden, such as insecticide-
treated bednets, Haemophilus influenzae type b vaccine, improvements
in access to safe drinking water, and wider use of cotrimoxazole and
anti-retroviral medications in HIV-infected persons [6–9].
We describe comprehensive findings from two years of
longitudinal, population-based surveillance at field clinics and
specific households in geographically defined locations in rural
western Kenya and an urban informal settlement in Nairobi for
respiratory illness, diarrhea and acute febrile illness.
Methods
Ethical review
Written informed consent was obtained for data collection at
the clinics and households. For minors, written informed consent
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was obtained from their parent or guardian. The protocol and
consent forms were reviewed and approved by the Ethical Review
Boards of the Kenya Medical Research Institute (KEMRI) (# 932)
and the Institutional Review Board of the U.S. Centers for Disease
Control and Prevention (CDC) (# 4566).
Surveillance sites
The Kenyan International Emerging Infections Program of
KEMRI/CDC has conducted population-based infectious disease
surveillance (PBIDS) since late 2005 in two sites in Kenya:
Asembo, a rural location in Nyanza Province in western Kenya
along Lake Victoria and within the Kibera informal settlement in
Nairobi (Table 1)[5,10–13].
Household surveillance
PBIDS household surveillance methods have been described
previously [10]. Briefly, all households in both surveillance sites are
offered enrollment. Eligible households are those located within
5 km and 1 km from the designated referral clinics for the project
in Asembo and Kibera, respectively. Eligible persons must have
resided permanently in these areas for 4 calendar months or be a
child born to a woman enrolled in PBIDS. Enrollment was
continuous in both sites since the project’s beginning. Community
interviewers visit enrolled households every two weeks (‘‘fortnight-
ly ’’ visits.) Participants are asked standardized questions, in local
language, about recent illnesses. For certain key symptoms—
cough, fever and diarrhea—the exact days of occurrence are
recorded. For older children (approximately over 12 years old) and
adults, interviews of that person are done. If not at home or unable
to answer questions, a proxy who is knowledgeable about the
participant’s health is interviewed. For children unable to answer
for themselves, the mother or other primary caretaker of the child
is interviewed. Abbreviated physical exams are carried out on ill
persons present during the visit, including axillary temperature, 1
minute respiratory rate, evaluation for lower chest wall indrawing
and stridor in ill children, and observation for signs of dehydration.
Community interviewers are secondary school graduates, who
undergo extensive training on data collection and physical
examination led by KEMRI/CDC clinicians, including WHO
Integrated Management of Childhood Illness (IMCI) training
videos [14].
Clinic surveillance
Centrally located clinics were identified and enhanced in each
surveillance area —in Asembo, St. Elizabeth Lwak Mission
Hospital, operated by the Franciscan Sisters of St. Anna
(henceforth referred to as ‘‘Lwak’’), and in Kibera, Tabitha
Clinic, operated by Carolina for Kibera (henceforth referred to as
‘‘Tabitha’’)]. Enrolled participants receive free medical care at the
study clinics for all acute, potentially infectious disease conditions,
including syndromes not targeted for surveillance, by KEMRI/
CDC-trained staff. Vital signs and symptoms are recorded by
nurses or trained health facility recorders (secondary school
graduates), and are verified by clinical staff. All temperatures are
axillary and respiratory rates are measured for 1 minute using an
audible countdown timer. Oxygen saturations are measured using
fingertip pulse oximeters (NONIN Medical, Minnesota). Most
examinations at both sites are carried out by clinical officers
(similar to physician’s assistants); two physicians at Tabitha Clinic
also examined patients. Malaria blood smears are performed on all
Table 1. Characteristics of study sites. Asembo, western Kenya and Kibera, Nairobi.
Characteristic Asembo (years) Kibera
Surveillance population, June 1,
2007, Total/,5 years
25,489/3,576 33,881/5,794
Area 100 km2 0.38 km2
Population density 325 persons per km2 77,000 persons per km2
Altitude in meters 1,100 meters 1,660 meters
Annual rainfall 1,358 mm* 558 mm[65]
Seasons Long rains (March–May), short rains (Oct–Nov) Long rains (March–May), short rains (Oct–Nov)
Average monthly temperature 24.5uC[65] 19.1uC average monthly temperature[65]
Breast-feeding Supplemental feeding until 6 months, then wean Supplemental feeding until 3–6 months, then wean
Malnutrition in children ,5 years old 33% stunting, 7% wasting* 33% stunting, 8% wasting*
HIV prevalence adults/newborns 18.5%/3% * 15.0%/Not available*
Malaria endemicity Holoendemic, year-round[5] Not endemic, but imported cases common
Slept under insecticide-treated
bednet last night (children ,5)
76%* (2008) N/A
Low birthweight births 15%[12] N/A
Health facilities 3 first-level MOH clinics in surveillance
site, and 3 more several km outside area
There are 5 registered non-MOH Health Centres within surveillance
area and 8 other health facilities within 1 km to 2.5 km
Immunization coverage** At 1 year, 79% DTP-HepB-Hib
dose 3, 70% measles*(2007)
N/A
Occupation household head Subsistence farming (65%), informal
economy (13%), salaried (5%)
Salaried (53%), informal economy (43%)
Cooking fuel Firewood (95%), charcoal (5%)* Charcoal (76%), kerosene (22%), others (2%)*
Ethnic groups Luo (.95%)[5] Luo (.60%)*
*KEMRI/CDC unpublished data.
**Pneumococcal conjugate and rotavirus vaccines were not available in Kenya during this period. N/A – not available.
doi:10.1371/journal.pone.0016085.t001
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patients with history of fever or documented temperature
$38.0uC. No x-rays were taken during the period described.
Blood and stool for culture and combined nasopharyngeal and
oropharyngeal swabs for PCR are collected from patients meeting
clinical indications (data not presented). Lwak hospital has 40
inpatient beds and manages most hospitalizations, only referring
complicated or surgical patients to the district hospital. Tabitha
Clinic does not have inpatient capacity, and refers patients for
hospitalization to a nearby district hospital.
Structured questionnaires detailing the current illness are
completed for all sick visits at Lwak and Tabitha. At Lwak,
scannable paper forms are used (TeleFormH software, CardiffTM,
Vista, CA). Inconsistent or illogical data are returned to the clinic
for correction. At Tabitha, data are entered directly into a custom-
designed computerized system with internal quality control checks.
Data analysis
Case definitions for infectious disease syndromes in the clinics
are provided in Table 2. For clinic visits, incidence rates were
calculated as the number of syndrome-specific visits per person-
year of observation. Revisits for the same illness episode were not
counted as separate episodes. For denominator calculations,
permanent residence status on enrolled participants in the
surveillance area was used to determine start and stop dates for
person-time contribution. Adjusted rates of clinic visitation were
calculated for each syndrome accounting for the percentage of all
clinic visits made for each syndrome that went to the study clinics
(i.e. Lwak, Tabitha) as opposed to other area clinics, as determined
from the household visits. Calculating case-fatality proportions in
the 30 days following a clinic visit was possible by longitudinal
follow-up of all participants at the households.
For household visits, slightly modified case-definitions were used
(Table 2). Because examination findings were part of the
household definitions for ALRI, adjustments to the household
ALRI rate were made for persons with cough or difficulty
breathing who did not have an examination, including temper-
ature, carried out at the household visit, assuming the same
percentage would have ALRI as those who had cough or difficulty
breathing and an exam done. Adjustments were made separately
for each age group. Reported, rather than documented, fever was
used to define AFI for household visits, as reported fever is
commonly used as a diagnostic criterion for malaria in endemic
areas and due to widespread use of antipyretics [14].
Although we asked about illness in the two weeks preceding home
visit, we previously showed a significant decay of the recall of
symptoms over that two week period, slightly impacted by age [10].
Therefore, to calculate the most accurate rates from the household
visits avoiding decay of recall with time, we only used symptoms
reported on the day of visit and the 3 previous days (days 0–3) for
children ,5 years and the day of visit and the 4 previous days (days
0–4) for persons $5 years, and adjusted the person-days calculations
accordingly. Longitudinal prevalence rates were calculated as total
number of days of a syndrome over total number of days of eligible
observation, converted to person-years of observation. For calculation
of longitudinal prevalence, the number of days of cough or difficulty
breathing (ARI), diarrhea, and fever (AFI) in persons meeting the case
definitions was used. Only days in which there was information as to
whether the symptom was present or absent were included in
denominators [10]. Prevalence rates for ALRI were not calculated
because only cough, one component of the ALRI definition, was
available for all days under surveillance. Incidence rates from
household visits were calculated as the number of new episodes per
person-year. We used a symptom-free interval for diarrhea of 3 days
and for cough and fever of 7 days to define new episodes of the same
syndrome [15,16]. Denominators were calculated as for longitudinal
prevalence, but, in addition, only days in which a new episode could
Table 2. Case definitions for major infectious disease syndromes from household and clinic surveillance in Asembo, western Kenya
(Lwak Hospital) and Kibera, Nairobi (Tabitha Clinic), June 1, 2006 – May 31, 2008.
Syndrome* Clinic Household
Children ,5 years Persons $5 years Children ,5 years Persons $5 years
Acute respiratory
infection (ARI)
($1 symptom): cough, difficulty
breathing, chest pain, sore throat,
sneezing, ear complaints or runny nose
cough or difficulty
breathing
Acute Lower Respiratory
Infection (ALRI)
cough or difficulty breathing
with one of the following: elevated
respiratory rate for age** (non-severe
pneumonia;) or IMCI danger sign***,
lower chest wall indrawing, stridor,
or oxygen saturation ,90%
(severe/very severe pneumonia) [14]
cough, difficulty breathing
or chest pain and either
documented axillary
temperature $38.0uC
or oxygen saturation
,90% [40]
cough or difficulty
breathing and rapid
respiration for age**
or chest indrawing
noted on exam
cough or difficulty
breathing or chest
pain and
documented
temperature
$38.0uC
on exam
Diarrhea $3 looser than normal stools in a
24 hour period. Severe defined as IMCI
danger sign or symptom/sign dehydration"
$3 looser than normal
stools in a 24 hour period
$3 looser than normal
stools in a 24 hour period
Acute Febrile Illness (AFI) documented axillary temperature $38.0uC
without an obvious cause, defined as cough,
difficulty breathing, chest pain, signs of
meningitis, or bloody diarrhea
(positive malaria smear is not an exclusion)
report of fever, without
evidence of another infection
defined as cough or difficulty
breathing or bloody diarrhea
*Episodes of illness could meet more than one case definition (e.g. ARI and ALRI, ARI and diarrhea, ALRI and diarrhea.) AFI is mutually exclusive with ARI/ALRI and some
types of diarrhea (i.e. bloody).
**Elevated respiratory rate for age based on WHO Integrated Management of Childhood Illness algorithm [14]; ,2months, $60 breaths/minute; 2–11 months, $50
breaths/minute;12–59 months, $40 breaths/minute.
***IMCI danger signs are maternal report of convulsions, inability to drink or breastfeed, or vomiting everything, or on exam lethargy or unconsciousness. [14]
"IMCI signs/symptoms of dehydration are the following: sunken eyes, slow skin pinch, restless/irritable behavior, drinking eagerly or not at all.[14]
doi:10.1371/journal.pone.0016085.t002
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be counted were included; therefore, subsequent days of an episode
after the first day and the days during the symptom-free interval were
excluded from the denominator [17].
For data collected from June 1, 2006 to May 31, 2008, we
modeled incidence and longitudinal prevalence of illnesses at the
household visits, and compared rural and urban rates, using Poisson
regression (PROC GENMOD, SAS version 9.1, SAS Institute,
Cary, North Carolina, USA). We controlled for clustering of
symptoms at the household level using generalizing estimating
equations (GEE). For the clinic visits, incidence rate ratios between
rural and urban sites were calculated using Breslow’s test for 95%
confidence intervals (PEPI, Sagebrush publishers). For comparisons
of adjusted rural and urban rates, the delta method was used [18].
We used incidence rates to project the number of cases of ALRI,
diarrhea, and AFI in Nyanza Province and among the urban slum
population in Nairobi, populations with similar epidemiology to
our surveillance populations. We used 2007 population projections
based on the 1999 national census, applying the same percentages
of the national population that was residing in Nyanza and
Nairobi Provinces, and assumed 60% of Nairobi residents were
residents of informal settlements [19–21]. Because our surveillance
sites were likely not representative of other provinces of Kenya in
terms of certain risk factors (e.g., HIV and malaria prevalence), we
did not make national projections during this analysis.
Results
General morbidity
There were 20,830 visits to the referral clinic in Asembo and
38,857 visits to Kibera during the study period, yielding overall
rates of clinic visitation of 0.43 per person-year and 0.69 visits per
person-year, respectively [Rate Ratio (RR) - 0.63, 95% CI 0.62–
0.64]. Clinic visit rates were highest in children ,5 years old (0.77
visits/person-year in Asembo, 2.4 visits/person-year in Kibera.)
Clinic visit rates were higher for all age groups ,35 years in
Kibera than Asembo, similar in persons 35–49 years and higher in
Asembo for persons $50 years.
During the study period, 1,181,788 interviews of household
members (or proxies) were completed in Asembo and 710,997 in
Kibera. For children ,5 years, illness episodes were reported
during the last two weeks in 40.3% of household visits in Asembo
compared with 13.7% in Kibera (RR=2.9, 95% CI 2.9–3.0). For
persons $5 years, illness episodes were reported during the last
two weeks in 28% of household visits in Asembo compared with
5.1% in Kibera (RR=5.4, 95% CI 5.4–5.5).
Acute Respiratory Infections
ARI was the most common syndrome in both sites (Table 3).
ARI rates were highest in young children, with cough or difficulty
breathing being reported for almost two full months per year in
Asembo and one month per year in Kibera for children ,5 years
old. ARI incidence was 5.6 times higher at the household visit than
at the clinic for children in Asembo and 5.1 times higher for adults.
In contrast, in Kibera the incidence detected for ARI in the
household was 0.89 times and 0.71 times the incidence in the clinic
for children and adults, respectively.
Acute lower respiratory tract infections. The rate of
ALRI resulting in clinic visitation was lower in Asembo than
Kibera among children ,5 years old (Table 4). Among children
,5 years old, 0.41% and 0.89% of ALRI episodes in the clinic
Table 3. Rates of Acute Respiratory Illness by age group from household and clinic surveillance in Asembo, western Kenya (Lwak
Hospital) and Kibera, Nairobi (Tabitha Clinic), June 1, 2006 – May 31, 2008.
Household visits Clinic visits
Longitudinal Prevalence Incidence Crude Incidence Adjusted Incidence*
Age Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI)
,1 year 69.0 39.4 1.8
(1.7–1.9)
9.53 4.90 2.0
(1.8–2.1)
0.80 2.47 0.32
(0.30–0.34)
1.83 5.89 0.31
(0.29–0.33)
12–23 mo. 63.6 29.5 2.2
(2.0–2.3)
8.60 3.61 2.4
(2.2–2.6)
0.65 1.78 0.38
(0.35–0.40)
1.39 3.81 0.37
(0.34–0.39)
24–59 mo. 55.9 21.7 2.6
(2.4–2.7)
7.21 2.76 2.6
(2.5–2.8)
0.62 1.24 0.50
(0.48–0.52)
1.27 3.24 0.39
(0.38–0.41)
,5 years 59.9 26.8 2.2
(2.2–2.3)
7.92 3.33 2.4
(2.3–2.5)
0.67 1.55 0.43
(0.42–0.45)
1.42 3.76 0.38
(0.37–0.39)
5–17 years 31.2 7.70 4.1
(3.8–4.3)
3.58 0.90 4.0
(3.7–4.2)
0.31 0.37 0.83
(0.80–0.86)
0.61 1.25 0.49
(0.47–0.51)
18–34 years 25.0 6.59 3.8
(3.6–4.0)
2.49 0.66 3.8
(3.5–4.0)
0.26 0.28 0.92
(0.88–0.96)
0.56 0.98 0.57
(0.55–0.60)
35–49 years 35.2 8.04 4.4
(4.0–4.8)
3.10 0.74 4.2
(3.8–4.6)
0.40 0.32 1.3
(1.2–1.3)
0.88 1.11 0.79
(0.74 –0.84)
$50 years 61.9 7.66 8.1
(7.0–9.3)
4.36 0.70 6.3
(5.3–7.4)
0.33 0.20 1.7
(1.5–1.9)
0.77 0.74 1.0
(0.94–1.1)
Total $5 years 35.8 7.26 4.9
(4.7–5.1)
3.38 0.77 4.4
(4.2–4.6)
0.31 0.31 0.99
(097–1.0)
0.66 1.08 0.61
(0.60–0.63)
*Adjusted clinic rates were calculated by extrapolating from those with same syndrome defined at household visit who sought care at a clinic besides the designated
referral clinics, Lwak and Tabitha (see methods). In Asembo, in the age categories ,1 year, 12–23 months, 24–59 months, ,5 years, 5–17 years, 18–34 years, 35–49
years, $50 years and $5 years, the percentage of all clinic visits for ARI to Lwak were 44%, 47%, 49%, 47%, 50%, 46%, 45%, 43%, and 47%, respectively. For Kibera, for
the same age groups, the percentages of all clinic visits for ARI to Tabitha were 42%, 46%, 38%, 41%, 30%, 29%, 29%, 27% and 29%, respectively.
Longitudinal prevalence is days of cough or difficulty breathing as part of an ARI episode per person-year. Incidence is number of episodes of ARI per person-year.
doi:10.1371/journal.pone.0016085.t003
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occurred in neonates in Asembo and Kibera, respectively. Persons
$5 years had much lower rates of ALRI than children in both
Asembo and Kibera. In contrast to all other syndromes, ALRI
rates were higher in the clinic than in the household. Among
children with ALRI seen in the clinic, 8.5% in Asembo and 2.0%
in Kibera had auscultatory wheezing reported on exam at the
clinic. Among children with ALRI in the clinic, 56% in Asembo
and 42% in Kibera met IMCI criteria for severe or very severe
pneumonia (Table 4). In Asembo, 3% of children with ALRI had
oxygen saturation ,90% and only 1% had oxygen saturation
,90% without other criteria for IMCI pneumonia of any severity;
7.5% of adults with ALRI had oxygen saturation ,90%. In
Kibera, 11% of children with ALRI had oxygen saturation ,90%
but none had oxygen saturation ,90% without other criteria for
IMCI pneumonia of any severity; 23% of adults with ALRI had
oxygen saturation ,90%. At Lwak Hospital, 64% of children and
34% of persons $5 years with ALRI were hospitalized.
Diarrhea. Rates for diarrhea resulting in clinic visit were
lower in Asembo than Kibera among children ,5 years (Table 5).
Among children ,5 years old, 0.42% and 0.37% of diarrhea
episodes in the clinic occurred in neonates in Asembo and Kibera,
respectively. On average, children ,5 years had 9.5 and 8.1
diarrhea days per year in Asembo and Kibera, respectively.
Persons $5 years had much lower rates of diarrhea than children
in both Asembo and Kibera. Numbers of diarrhea episodes as
reported in the household were 6-fold and 2-fold higher than those
seen in the referral clinics in Asembo and Kibera, respectively.
Among children with diarrhea visiting the referral clinics, 40% in
Asembo and 11% in Kibera had a sign of dehydration or an IMCI
danger sign. At Lwak, 26% of children and 20% of persons $5
years with diarrhea were hospitalized.
Acute Febrile Illness. In contrast to the other 3 syndromes,
clinic visitation rates for AFI were higher in Asembo than Kibera
among children ,5 years, likely due to greater malaria prevalence
in rural western Kenya (Table 6). Among children ,5 years old,
0.34% and 0.42% of AFI episodes in the clinic occurred in
neonates in Asembo and Kibera, respectively. On average,
children ,5 years had 37 and 11 fever days per year in Asembo
and Kibera, respectively. Persons $5 years had much lower rates
of AFI than children in both Asembo and Kibera. Among children
with AFI in the clinic who had a blood smear done, 68% in
Asembo and 23% in Kibera had malaria parasites seen. At Lwak
Hospital, 40% of children and 28% of persons $5 years with AFI
were hospitalized.
Mortality. For illness episodes presenting at the clinic, the
case-fatality ratio was higher for all illnesses for children and adults
in Asembo than Kibera (Table 7). Overall, mortality rates were
also higher for all groups in Asembo than Kibera, particularly at
the extremes of age (Figure 1)
Burden projections. The projected number of episodes of
illness in 2007 was substantial in both Nyanza province
(population of 4.3 million in 1999) and the informal settlements
of Nairobi, ranging up to almost 27 million episodes of AFI in
Nyanza Province (Table 8).
Discussion
Our longitudinal, population-based surveillance provides one of
the few recent, comprehensive estimates of infectious disease
burden in Africa, being unique in measuring burden for multiple
infectious disease syndromes using common methodology in both
rural and urban settings among children and adults, and in
surveying at both clinics and in the household. Household visits
served two purposes. First, they were used to encourage ill
participants to access the referral clinic. Second, household visits
were useful in interpreting and adjusting incidence rates. Shops
and drug-sellers are more common sources of healthcare than
licensed clinics in both areas [22,23]. Multiple factors influence
healthcare utilization at clinics, including cost, distance, quality of
care, and severity of syndrome [24–27]. Even when offering free
Table 4. Rates of Acute Lower Respiratory Illness by age group from household and clinic surveillance in Asembo, western Kenya
(Lwak Hospital) and Kibera, Nairobi (Tabitha Clinic), June 1, 2006 – May 31, 2008.
Household visits Clinic visits
Incidence* Crude Incidence Adjusted Incidence**
Age Asembo Kibera RR (95% CI) Asembo Kibera RR (95% CI) Asembo Kibera RR (95% CI)
,1 year 0.65 0.34 1.9 (1.5–2.5) 0.20 0.67 0.29 (0.26–0.33) 0.44 0.87 0.51 (0.45–0.57)
12–23 mo. 0.51 0.34 1.5 (1.2–2.0) 0.21 0.62 0.34 (0.31–0.39) 0.47 0.74 0.63 (0.56–0.71)
24–59 mo. 0.11 0.093 1.2 (0.90–1.7) 0.13 0.26 0.50 (0.46–0.55) 0.26 0.31 0.83 (0.76–0.92)
,5 years 0.29 0.19 1.5 (1.3–1.8) 0.16 0.41 0.40 (0.37–0.42) 0.36 0.51 0.70 (0.66–0.75)
5–17 years 0.03 0.009 3.6 (2.4–5.4) 0.043 0.036 1.2 (1.1–1.3) 0.083 0.045 1.9 (1.7–2.1)
18–34 years 0.01 0.005 2.5 (1.4–4.5) 0.025 0.012 2.1 (1.8–2.5) 0.051 0.016 3.2 (2.7–3.8)
35–49 years 0.02 0.008 2.7 (1.3–5.7) 0.039 0.014 3.0 (2.3–3.9) 0.082 0.019 4.3 (3.4–5.6)
$50 years 0.014 0 NA 0.029 0.010 2.92 (1.9–4.4) 0.068 0.015 4.6 (3.1–7.0)
Total $5 years 0.02 0.007 3.3 (2.5–4.5) 0.033 0.020 1.7 (1.5–1.8) 0.067 0.026 2.6 (2.4–2.8)
*Rates from household visits for ALRI are adjusted by the percentage of persons with reported cough or difficulty breathing who did not have an exam done at home
(see methods). In Asembo, in the age categories ,1 year, 12–23 months, 24–59 months, ,5 years, 5–17 years, 18–34 years, 35–49 years, $50 years and $5 years, these
percentages were 29%, 33%, 46%, 39%, 72%, 41%, 33%, 24%, and 49%, respectively. For Kibera, for the same age groups, the percentage without an exam were 36%,
33%, 43%, 38%, 60%, 21%, 30%, 37%, and 40%, respectively.
**Adjusted clinic rates were calculated by extrapolating from those with same syndrome defined at household visit who sought care at a clinic besides the designated
referral clinics, Lwak and Tabitha (see methods). In Asembo, in the age categories ,1 year, 12–23 months, 24–59 months, ,5 years, 5–17 years, 18–34 years, 35–49
years, $50 years and $5 years, the percentage of all clinic visits for ALRI to Lwak were 45%, 45%, 51%, 46%, 51%, 49%, 48%, 43%, and 49%, respectively. For Kibera, the
percentage of all clinic visits for ALRI to Tabitha 77%, 84%, 84%, 82%, 81%, 76%, 69%, 68%, and 77%, respectively.
Incidence is number of episodes of ALRI per person-year.
doi:10.1371/journal.pone.0016085.t004
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high-quality care as part of surveillance, many ill persons did not
access our designated referral clinics, particularly in the rural area,
where only 30–40% of ill participants sought care at any clinic and
only a half of these at the project’s designated referral clinic,
percentages that did not vary substantially during the surveillance
period [28]. Rates of ARI, diarrhea and AFI, but not ALRI, were
higher when calculated from household visits than from clinic
data. The higher rates of ALRI in the clinic than the household is
likely due to differences in the case definitions used in the clinic
and household, as well as a higher percentage of persons with
ALRI visiting clinics due to the greater severity of illness than the
other syndromes. The smaller difference between clinic and
household rates of disease in Kibera than Asembo is because
healthcare utilization overall, and particularly to the designated
referral clinic, was higher in the urban site [22,23,28]. Distance of
residence to clinic clearly influences health utilization [26]; those
distances are much less in Kibera. In addition it is possible that
people living in Kibera are more educated and comfortable with
use of licensed clinic facilities than residents in Asembo, a remote
rural area. Nonetheless, our findings suggest that a substantial
burden of infectious disease illness does not present to the clinic,
especially in rural Africa, highlighting the need for preventive
measures (e.g. vaccines, insecticide-treated bednets) and non-
clinic-based case management strategies in such settings [29–34].
Community-based studies of clinically-defined ALRI in African
children have yielded varied incidences, with our estimates (0.29
per person-year rural, 0.19 per person-year urban) falling in the
middle of the range when compared with peri-urban Nigeria (1.3
episodes/person-year), rural Gambia (0.45 episodes/person-year),
urban Nigeria (0.08–0.22 episodes/person-year), rural central
Kenya (0.21 episodes/person-year), and rural Ghana (0.06
episodes/person-year) [8,9,35–38]. The reason for higher rates
of wheezing in children in the rural area when compared with
urban in our study might be related to greater exposure to indoor
air pollution from cooking with firewood in the rural area
(Table 1), but could also be related to the frequency of certain viral
infections (e.g. RSV) [39]. For ARI in children, the incidence we
found (7.9 episodes/person-year rural, 3.5 episodes/person-year
urban) is similar to rates from other community-based African
studies – rural Kenya, 6.6 episodes/person-year, urban Nigeria 8.1
episodes/person-year [9,37,38].
While facility-based data on respiratory illness in adults exist,
there have been no community-based data [40–45]. The facility-
based rates of ALRI we estimate of 67 and 26 per 1,000 person-
years in rural and urban Kenya, respectively, are on the higher
end of estimates found in other studies in Africa, being more
comparable with rates in HIV-infected populations (37–69 per
1000) [40,43,45]. Among HIV-negative or HIV-status unknown
adult populations in Africa, ALRI rates have ranged from 2–10
per 1,000 [40,41,44,46,47]. There are several reasons likely res-
ponsible for the somewhat higher rate of adult ALRI we found.
First, both our populations have high rates of adult HIV infection
(15–18%, KEMRI/CDC data.) Second, we used a clinical ALRI
definition that might have captured upper respiratory and
influenza-like illness, in addition to ALRI [48]. Third, we collected
longitudinal data in relatively small populations, and provided
free, high-quality healthcare, which could have led to higher levels
of health facility utilization than in other African studies.
The incidence rate of diarrhea we found in children of 1.9–2.2
episodes per child-year is lower than other estimates in Africa from
Table 5. Rates of diarrhea by age group from household and clinic surveillance in Asembo, western Kenya (Lwak Hospital) and
Kibera, Nairobi (Tabitha Clinic), June 1, 2006 – May 31, 2008.
Household visits Clinic visits
Longitudinal Prevalence Incidence Crude Incidence Adjusted Incidence*
Age Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI)
,1 year 16.1 11.8 1.4
(1.2–1.5)
3.25 1.88 1.7
(1.5–2.0)
0.35 0.96 0.36
(0.33–0.40)
0.73 1.28 0.57
(0.52–0.63)
12–23 mo. 17.3 12.9 1.3
(1.2–1.5)
4.04 2.32 1.7
(1.6–2.0)
0.24 0.79 0.31
(0.28–0.34)
0.53 0.93 0.57
(0.52–0.64)
24–59 mo. 4.9 5.1 0.96
(0.86–1.1)
1.29 0.98 1.3
(1.2–1.5)
0.10 0.39 0.26
(0.23–0.29)
0.21 0.47 0.45
(0.40–0.49)
,5 years 9.5 8.1 1.2
(1.2–1.3)
2.19 1.43 1.5
(1.4–1.7)
0.19 0.57 0.33
(0.31–0.34)
0.40 0.71 0.56
(0.53–0.60)
5–17 years 1.2 0.66 1.7
(1.5–1.9)
0.35 0.15 2.4
(2.3–2.7)
0.031 0.059 0.53
(0.47–0.58)
0.066 0.071 0.93
(0.84–1.03)
18–34 years 1.8 0.52 3.5
(3.1–4.0)
0.44 0.11 4.0
(3.5–4.6)
0.047 0.039 1.2
(1.1–1.4)
0.095 0.054 1.8
(1.6–2.0)
35–49 years 2.8 0.73 3.8
(3.2–4.6)
0.70 0.15 4.6
(3.9–5.5)
0.071 0.051 1.4
(1.2–1.6)
0.14 0.079 1.8
(1.5–2.1)
$50 years 3.8 0.73 5.3
(4.0–6.9)
1.07 0.17 6.2
(4.7–8.2)
0.051 0.040 1.3
(1.0–1.6)
0.11 0.053 2.1
(1.7–2.6)
Total $5
years
2.0 0.61 3.3
(3.0–3.5)
0.55 0.13 4.1
(3.8–4.5)
0.043 0.047 0.92
(0.87–0.98)
0.090 0.062 1.5
(1.4–1.6)
*Adjusted clinic rates were calculated by extrapolating from those with same syndrome defined at household visit who sought care at a clinic besides the designated
referral clinics, Lwak and Tabitha (see methods). In Asembo, in the age categories ,1 year, 12–23 months, 24–59 months, ,5 years, 5–17 years, 18–34 years, 35–49
years, $50 years and $5 years, the percentage of all clinic visits for diarrhea to Lwak were 47%, 45%, 48%, 47%, 47%, 49%, 50%, 47%, and 48%, respectively. For Kibera,
for the same age groups, the percentage of all clinic visits for diarrhea to Tabitha were 75%, 85%, 82%, 81%, 84%, 73%, 65%, 76%, and 76%, respectively.
Longitudinal prevalence is days of diarrhea per person-year. Incidence is number of episodes of diarrhea per person-year.
doi:10.1371/journal.pone.0016085.t005
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the 1980s [7]. In a study from urban Nairobi, among children ,3
years, 3.5 diarrheal episodes per year were recorded, whereas in
Guinea-Bissau and Zaire 10.4 and 6.3 episodes per year,
respectively, were recorded in children ,5 years [7,49–51]. It is
possible that in the two decades since most earlier studies were
undertaken that diarrhea disease rates have decreased in Africa
due to interventions such as safe-water promotion, better hygiene,
increased measles vaccination coverage, and reduced malnutrition
[6]. Alternatively, differences in methodology, such as frequency of
visits, or cultural concepts about what constitutes ‘‘diarrhea’’ could
have contributed. Few community-based studies estimate diarrhea
rates in African adults. In rural Uganda during weekly household
visits, HIV-positive persons $5 years not on cotrimoxazole
prophylaxis had 194 diarrheal episodes per 100 person-years,
while HIV-negative persons $10 years living in the same
households experienced 15.5 episodes per 100 person-years
[52,53]. We found diarrhea rates in adults (rural, 55 per 100
person-years; urban, 13 per 100 person-years) closer to the HIV-
negative Ugandan population.
Rates of AFI are not usually calculated in African settings,
despite fever usually being the most common presenting symptom
[54–57]. More often, rates of specific etiologies of febrile illness are
reported. Invasive bacterial disease rates among children range
from 505 to 1,100 episodes per 100,000 person-years in various
African settings [35,58,59]. These were estimates from hospital-
based studies, and likely underestimate the true rate. A majority
(up to 80%) of malaria illness never gets diagnosed in the
community because of low levels of healthcare seeking and lack of
laboratory testing [60]. Estimates of malaria rates in children are
obtained from control groups during recent studies of candidate
malaria vaccines, where symptomatic malaria incidence ranged
from 17–26 per 100 person-years [29,33]. We found clinic rates of
AFI among children that were lower than the symptomatic
malaria incidence rates from these trials, but higher than the
invasive bacterial disease rates. At the household visits, we found
AFI incidence was several-fold higher, with children experiencing
10 febrile episodes a year in the rural site and 3 in the urban site.
Among adult African populations, even less incidence data on
AFI are available. From control arms of clinical trials in malaria-
endemic areas of western Kenya, incidence rates of symptomatic
and asymptomatic malaria parasitemia were 1–2 episodes per
person-year [61,62]. One review estimated the typhoid rate to be
39/100,000 in East Africa [54]. The incidence of AFI defined in
Table 6. Rates of acute febrile illness (AFI) by age group from household and clinic surveillance in Asembo, western Kenya (Lwak
Hospital) and Kibera, Nairobi (Tabitha Clinic), June 1, 2006 – May 31, 2008.
Household visits Clinic visits
Longitudinal Prevalence Incidence Crude Incidence Adjusted Incidence*
Age Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI) Asembo Kibera
RR
(95% CI)
,1 year 45.2 17.9 2.5
(2.4–2.7)
12.0 4.2 2.9
(2.6–3.1)
0.046 0.092 0.50
(0.38–0.66)
0.11 0.12 0.92
(0.70–1.21)
12–23 mo. 42.1 14.1 3.0
(2.8–3.2)
11.4 3.4 3.4
(3.1–3.7)
0.080 0.087 0.92
(0.74–1.2)
0.17 0.11 1.6
(1.3–2.0)
24–59 mo. 32.8 8.1 4.0
(3.8–4.3)
8.9 1.9 4.6
(4.3–4.9)
0.088 0.062 1.4
(1.2–1.7)
0.18 0.076 2.4
(2.1–2.8)
,5 years 37.0 11.3 3.3
(3.1–3.4)
9.9 2.7 3.8
(3.6–3.9)
0.077 0.073 1.1
(0.94–1.2)
0.17 0.090 1.9
(1.7–2.1)
5–17 years 15.1 2.5 6.1
(5.7–6.4)
3.9 0.57 6.7
(6.3–7.2)
0.022 0.020 1.1
(0.94–1.3)
0.047 0.026 1.9
(1.6–2.1)
18–34 years 12.6 2.8 4.6
(4.3–4.9)
2.7 0.54 4.9
(4.6–5.2)
0.0085 0.007 1.2
(0.94–1.6)
0.019 0.010 1.9
(1.5–2.5)
35–49 years 20.5 3.8 5.4
(5.0–5.9)
3.7 0.72 5.2
(4.7–5.7)
0.007 0.007 1.0
(0.65–1.6)
0.016 0.011 1.5
(0.98–2.4)
$50 years 31.1 3.4 9.2
(7.8–10.9)
4.3 0.58 7.3 (6.2–8.7) 0.0031 0.002 1.6
(0.61–4.0)
0.008 0.0029 2.7
(1.01–7.1)
Total $5
years
18.1 2.8 6.4
(6.1–6.7)
3.6 0.58 6.2
(6.0–6.5)
0.013 0.011 1.1
(0.96–1.2)
0.030 0.015 1.8
(1.6–2.0)
*Adjusted clinic rates were calculated by extrapolating from those with same syndrome defined at household visit who visited a clinic besides the designated referral
clinics, Lwak and Tabitha (see methods). In Asembo, in the age categories ,1 year, 12–23 months, 24–59 months, ,5 years, 5–17 years, 18–34 years, 35–49 years, $50
years and$5 years, the percentage of all clinic visits for AFI to Lwak were 42%, 47%, 48%, 46%, 46%, 44%, 44%, 40%, and 44%, respectively. For Kibera, for the same age
groups, the percentage of all clinic visits for AFI to Tabitha were 78%, 83%, 82%, 81%, 78%, 70%, 67%, 69%, and 73%, respectively.
Longitudinal prevalence is days of fever as part of an AFI per person-year. Incidence is number of episodes of AFI per person-year.
doi:10.1371/journal.pone.0016085.t006
Table 7. Case-fatality ratio (# deaths/# cases) by syndrome,
within 30 days of clinic visit date.
ALRI Diarrhea AFI
Asembo (for all patients/for admitted patients)
,5 years 1.7%/2.6% 1.5%/4.6% 0.51%/1.3%
$5 years 2.1%/5.1% 2.8%/9.9% 0.55%/2.0%
Kibera
(for all patients)
,5 years 0.23% 0.19% 0.13%
$5 years 0.31% 0.22% 0.37%
doi:10.1371/journal.pone.0016085.t007
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the household for persons$5 years in our surveillance was several-
fold higher than either these malaria or typhoid rates, suggesting
that these diseases, particularly malaria, may be under-diagnosed
and, perhaps more importantly, broader diagnostic testing is
needed to elucidate the multiple causes of fever in older children
and adults in Africa.
The mortality pattern in our surveillance areas, with highest
rates among young children then rising again in young adults, is
typical of parts of Africa with high levels of HIV [1,2]. Mortality
and case-fatality ratios following clinic visits were higher in
Asembo than Kibera. There are several potential reasons for this
difference. First, Tabitha clinic sees more patients than Lwak
Hospital, likely reflecting greater healthcare use for milder illness
[26]. Because of this, illness episodes might be treated at an earlier
stage preventing progression to severe disease, which in turn would
result in lower overall mortality. Second, more challenging access
to quality health care (because of distance and poor roads,
especially during rainy seasons) might have resulted in later
presentation of illness in the rural setting. Third, some diseases,
particularly malaria, are more prevalent in the rural area. Lastly,
there might have been surveillance bias. Many residents of Kibera
consider their ancestral home to be elsewhere in Kenya, and it is
culturally important to be home for death and burial; thus, it is
possible that pre-terminal patients would go ‘‘up-country’’ to die,
and not be reported or counted as deaths in the Kibera
surveillance system.
Besides incidence, we also report on longitudinal prevalence
from the household visits, which is the cumulative number of days
over a given time period in which a person is ill [63,64].
Longitudinal prevalence might be a better measure of illness
burden, because unlike incidence, it accounts for both the number
and duration of illness episodes. Longitudinal prevalence has been
more closely correlated with growth faltering and mortality in
children with diarrhea than has incidence [63,64]. Longitudinal
prevalence of fever and lower respiratory tract infections in
children has also been associated with growth faltering, but has not
been evaluated as a disease burden measure in adults [65].
We encountered several challenges when comparing rates of
disease in the clinic and the community. The specificity of the case
definitions for the same syndrome likely differed for household-
and clinic-based surveillance. While trained field workers evalu-
ated participants in the household visits, clinicians did so in the
clinics, where they could verify reported symptoms based on their
clinical assessment of the patient. Also, patients were likely to be
sicker when seen in the clinic than at the household visit and so
had a greater prior probability of having the syndromes under
Table 8. Number of episodes of ALRI, diarrhea and AFI estimated to have occurred in Nyanza Province and informal Nairobi
settlements in 2007 based on household (HH)- and clinic-based surveillance, Kenya.
Nyanza Province Nairobi informal settlements
,5 years $5 years ,5 years $5 years
2007 Projected population 980,089 4,679,199 336,463 1,606,363
ALRI: Incidence* (HH/Clinic)
Episodes (HH/Clinic)
0.29/0.36
284,226/
352,832
0.02/0.067
93,584/
313,506
0.19/0.51
63,928/
145,011
0.007/0.026
11,245/
35,294
Diarrhea: Incidence* (HH/Clinic)
Episodes (HH/Clinic)
2.19/0.40
2,146,396/
392,035
0.55/0.09
2,573,560/
421,128
1.43/0.71
481,143/
201,878
0.13/0.062
208,827/
84,164
AFI: Incidence* (HH/Clinic)
Episodes (HH/Clinic)
9.9/0.17
9,702,886/
166,615
3.6/0.03
16,845,117/
140,376
2.7/0.09
908,451/
25,590
0.58/0.015
931,691/
20,362
*Incidence is number of episodes per person-year from tables 4–6.
doi:10.1371/journal.pone.0016085.t008
Figure 1. Overall mortality rates by age for Asembo and Kibera in areas of population-based surveillance.
doi:10.1371/journal.pone.0016085.g001
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surveillance. Our decisions whether to use reported versus
documented findings was based on previously used diagnostic
criteria [8,14]. While reported symptoms in the household might
have had reduced specificity (e.g. AFI), using an exam-based case
definition in the household introduced other complications
because a person must be at home and acutely ill at the time of
the biweekly household visit to capture abnormal signs. In using an
exam-based definition at the household for ALRI, we adjusted
rates to compensate for individuals who might have had ALRI
who did not have an exam done, an adjustment that could have
been prone to bias if those without exams were more or less likely
to have ALRI than those with exam.
We adjusted clinic rates to avoid underestimation of the true
burden that would result from basing calculations on only one
clinic in sites where multiple clinics were available to the
population. We assumed that those illnesses episodes in which
care was sought at another local clinic were likely to be of
equivalent severity. Similar adjustments to incidence rates based
on persons not sampled have been made before for estimates of
acute febrile illness in Egypt [55]. It is possible though that those
illness episodes that resulted in a visit to the referral clinic were not
the same as those that went to other clinics. In Asembo, the bias
might have been for more severe illnesses to visit Lwak, where
people knew admission would be free. Whereas in Kibera, the
opposite might have been the case, whereby ill persons who felt
they would need hospitalization would bypass Tabitha and go
directly to an inpatient hospital.
In conclusion, disease burden estimates such as this derived
from local surveillance data can provide credible data to decision
makers about the need for targeted interventions and what health
and economic impact such interventions might yield. We
demonstrated that disease rates in the community are higher in
rural than urban Kenya, although clinic-based rates tend to be
higher in the urban setting, where health utilization is better. We
also showed that in rural Kenya many illness episodes are missed
at the clinic and the burden of infectious diseases is likely several-
fold higher than can be measured at the clinic. Such data suggest
interventions to improve health care access or to implement non-
facility based treatment strategies, such as effective home-
management of malaria and diarrhea, might have a large public
health impact in rural Africa [30]. Both communities had an
intolerable burden of illness, with children experiencing illness in
up to one-quarter of the year. Proven interventions, such as
insecticide-treated bednets and the pneumococcal conjugate and
rotavirus vaccines, are urgently needed to alleviate this burden
[31,32,34]. Without more effective interventions to control these
common infectious disease syndromes, continued high morbidity
and mortality in poor African settings will continue to hamper
development of these communities.
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